{"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"70"}]}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"80"}],"units":"Participants"}],"description":"An adverse event (AE) is defined as any untoward medical occurrence in a participant, temporally associated with the use of a medicinal product, whether or not considered related to the medicinal product. The investigator assessed relatedness between the AE and the investigational product.","groups":[{"description":"Participants received pazopanib 800 milligrams (mg) once daily.","id":"OG000","title":"Pazopanib 800 mg"}],"paramType":"NUMBER","populationDescription":"ATS Population","reportingStatus":"POSTED","timeFrame":"From Baseline to Follow-up (up to 6.230 years)","title":"Number of Participants With Adverse Events Related to Investigational Product","type":"PRIMARY","unitOfMeasure":"participants"}